Valued at $66.0M at its later-stage round, Jun 2023. Nothing has traded since.
- ·The complete investor list: 15 names
- ·Watch Veralox Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Veralox Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2023 | Early Stage VC | $24.0M | ▮ | ▮ |
| Jun 2021 | Early Stage VC | $14.4M | ▮ | ▮ |
| May 2019 | Debt | $1.5M | ▮ | ▮ |
Membership and data by Private Market View
Veralox Therapeutics valuation
Veralox Therapeutics was valued at $66 million at its later-stage round in Jun 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Veralox Therapeutics raised?
Veralox Therapeutics has raised $41.2 million across 3 recorded rounds since 2019. The largest was a $24 million early-stage round in Jun 2023.
Veralox Therapeutics has filed 3 Form Ds with the SEC since 2019, most recently in Jun 2023 ($24 million sold to 14 investors).
How Veralox Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Veralox Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Veralox Therapeutics
- What is Veralox Therapeutics worth?
- Veralox Therapeutics is valued at $66.0M as of Oct 2026. Valued at $66.0M at its later-stage round, Jun 2023. Nothing has traded since.
- How much has Veralox Therapeutics raised?
- Veralox Therapeutics has raised $41.2M in total funding across 3 recorded rounds.
- When did Veralox Therapeutics last raise?
- Veralox Therapeutics last raised in Jun 2023 (Early Stage VC), raising $24.0M.